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Abstract:  Osteoporotic  vertebral  fractures  are  associated  with  considerable  reduction  of 
quality of life, morbidity, and mortality. The management of patients with vertebral fractures 
should include treatment for osteoporosis and measures to reduce pain and improve mobility. 
This article provides information for management and rehabilitation of vertebral fractures 
based on clinical experience and literature.
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Introduction
Health consequences from osteoporotic fractures in women include disability and 
increased mortality. As a result vertebral fractures have a negative impact on the   quality 
of life and their presence is linked with cardiopulmonary morbidities,   depression and 
death.1–6
The most important target is to prevent these fractures, but if a fracture exists the 
focus shifts to rehabilitation and prevention of the next fracture. Lindsay et al confirmed 
that women who develop a vertebral fracture are at substantial risk for additional 
fracture within the next year.7
Musculoskeletal pain, common in patients with osteoporotic vertebral fractures, is 
one of the most frequent symptoms for which medical assistance is sought. Osteoporosis 
represents one of the main causes of back pain in postmenopausal women.8 Although, 
in the same population, nonosteoporotic vertebral deformities are seen as often as 
osteoporotic ones, and they are also a main cause of back pain. In women up to 60 years 
back pain was found to be mostly due to degenerative disorders of the spine.9
Clinical or subclinical vertebral fractures are a common cause of back pain. 
  Vertebral fractures cause acute pain in the back in the acute phase of the fracture and 
chronic pain resulting from the associated skeletal deformity, joint incongruity, and 
tension on muscles and tendons,10 leading to disability. It is surprising that most of 
these patients do not receive an antiosteoporotic treatment.11
Targeted osteoporotic drug treatment
Pharmacologic treatment should be prescribed for those who have sustained vertebral 
fractures.11 In fact in a retrospective study only 15% of medical records indicated that 
fracture patients had been prescribed antiosteoporotic medications within one year 
after discharge from hospital.12,13 International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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The therapeutic effect of bisphosphonates on back 
pain has rarely been reported on in patients with vertebral 
  fractures.14 Nevitt et al have reported the efficacy of long-term 
treatment with alendronate in elderly osteoporotic patients for 
reducing the burden of activity limitation and bed disability 
caused by back pain.14,15 A valuable drug in the rehabilita-
tion process of elderly patients suffering from back pain due 
to osteoporotic vertebral collapse seems to be intravenous 
pamidronate.14,16
Armingeat et al in their controlled trial of intravenous 
pamidronate comparing placebo for pain relief in recent 
osteoporotic vertebral compression fractures found a rapid, 
marked, and sustained analgesic effect of pamidronate for 
reducing acute back pain due to recent osteoporotic vertebral 
fracture, without any significant safety concerns.17
In a review article Ulivieri stated that treating patients 
with antiresorptive and anabolic agents reduces the risk of 
new or worsening back pain, particularly with teriparatide 
therapy.18 In line with this paper Nevitt et al in a meta-
  analysis, concluded that teriparatide had a reduced risk of 
new or worsening back pain compared to patients randomized 
to placebo, hormone replacement therapy, or alendronate.19 
In a retrospective analysis, Lindsay et al reported that the 
presence of one or more vertebral fractures resulted in a 
five-fold increase in risk for sustaining a subsequent vertebral 
fracture.20 Therapeutic options can reduce the number of new 
vertebral compression fractures by 40%–60% within the first 
year in individuals with a fracture.21
Calcium, vitamin D, and vitamin D 
analogues21
Pooled data comparing vitamin D alone with placebo or no 
treatment showed no statistically significant effect on vertebral 
fracture or deformity.22 Vitamin D (including 25-hydroxy 
  vitamin D) with calcium was no more effective than calcium 
alone on vertebral fracture. Evidence has shown that vitamin D 
alone was less effective than calcium for the prevention of 
vertebral fracture or deformity. There was no evidence of a 
statistically significant preventive effect on clinical vertebral 
fractures from the administration of vitamin D and calcium 
and vitamin D plus calcium versus placebo or no treatment. In 
participants with osteoporosis no   statistically significant effect 
of alfacalcidol (1-alpha-  hydroxy vitamin D3) compared with 
vitamin D and calcium on people with new vertebral deformi-
ties was found. Calcitriol (1,25   dihydroxy vitamin D3), and 
additional supplementation with calcitriol in people with 
osteoporosis who were already taking   calcium had no statisti-
cally significant effect on new vertebral deformity. No statisti-
cally significant effect on the number of people developing 
new vertebral   deformities receiving calcitriol plus vitamin 
D and calcium versus vitamin D and calcium was found. 
Overall, there was no statistically significant effect on the 
incidence of vertebral deformities with calcitriol versus 
calcium. When calcitriol was compared with vitamin D 
in people with pre-existing osteoporosis no statistically 
significant effect was seen for vertebral deformities.
Other interventions
Back pain in the majority of these patients is treated with 
  prolonged bed-rest, local and systemic analgesia, and 
  bracing.23 Thereby, the incidence of a vertebral fracture 
should be followed by a limited period of bed rest, to 
avoid the hazards of deconditioning, accelerated bone loss, 
deep venous thrombosis, pneumonia, decubitus ulcers, 
  disorientation, and depression.24,25
The extension of bed-rest in these patients results in 
increase of bone loss (identified by increase of hydroxyproline 
excretion) and muscle weakness and joint stiffness. Another 
interesting aspect is that most osteoporotic vertebral fractures 
happen in high bone turnover patients, and in these patients 
postfracture immobilization is an additional risk factor of 
increased bone loss.26 Nasal salmon calcitonin in a daily dose 
of 200 IU has an equivalent analgesic effect to 100 IU of 
injectable salmon calcitonin.21,27,28 The analgesic efficacy of 
nasal calcitonin was tested in 32 men and 68 postmenopausal 
women with a mean age of 76 and 71 years respectively, who, 
within the previous 5 days, had sustained a nontraumatic 
vertebral fracture which had been confirmed radiographically 
and clinically.13 The patients were hospitalized for a period of 
28 days and were randomly assigned to receive either 200 IU 
of nasal salmon calcitonin or a matching nasal placebo spray. 
In addition patients were permitted to take paracetamol as a 
rescue analgesic up to 6 tablets of 500 mg daily. Treatment 
was initiated after baseline measurements on day 0. Pain 
evaluation was performed daily using a 10-degree visual 
analog scale (VAS) (0 = no pain, 10 = agonizing pain). Pain 
was tested during different locomotor functions eg, bed rest, 
sitting, standing, and walking. In our experience if a patient 
records a pain above 7 (in the VAS scale) he is not capable 
of attempting the recommended locomotor function. In turn, 
a rating of pain less than 7 suggests that the patient does 
not require nursing and bed rest and that he is able to begin 
physiotherapy. After the completion of 28 days of follow-up 
it was found that pain was reduced dramatically in the group 
receiving calcitonin (P , 0.001). The analgesic effect of 
nasal calcitonin was negatively associated with the number of International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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paracetamol tablets consumed. The VAS pain rating showed 
that most patients gradually gained full mobility after the first 
week of calcitonin treatment. The number of patients who 
remained bedridden was significantly higher in the placebo 
group at all time points than in the calcitonin group.13
Spinal compression fracture and pain can produce an 
imbalance between the use of back extensors (the major trunk 
supportive muscles) and flexors. To decrease painful contrac-
tions of the erector spinae muscles, one needs to decrease 
the load over the anterior aspect of the spinal column and 
vertebral bodies.
Bracing is used in acute nonsurgical management, whereas 
spinal orthoses relieve the pain and promote the healing pro-
cess by stabilizing the spine. It should be noted that the latter 
reduces the load applied on the anterior column and vertebral 
body by restraining any attempt of forward flexion. Even 
though there is a lack of specific studies comparing various 
types of orthoses, it is widely accepted that all spine orthoses, 
whether made of cloth, metal, or plastic, and whether rigid or 
flexible, use a three-point pressure system.24,25
The most broadly used types of spinal orthoses in 
Greece24 are: a) the TLSO type that provides support to the 
thoracolumbosacral spine by making it adopt an anatomically 
correct position (Knight-Taylor, Jewett, CASH, or Cruciform 
Anterior Sternal, Boston, MA), b) the posture training sup-
port (PTS) type, which is a device that has shoulder straps 
joining above the waist at the back, where a pouch holds small 
weights,29 c) Spinomed®, the new ‘bracing’ philosophy, based 
on biofeedback theory30 and d) Osteomed®, which is based 
upon the gate control theory of pain.31,32
Kaplan et al pointed out that orthotic devices impose a 
risk of reduction in muscular strength. Their controlled pilot 
study with a 4-week observation period demonstrated that 
the strength of the back extensors was reduced to below the 
initial value in 40% of female patients wearing a stable orthotic 
device.33 On the contrary we published recently preliminary 
results of women with established osteoporosis and/or an 
angle of kyphosis more than 55 degrees wearing Spinomed 
orthosis for at least 2 hours/day for 6 months showing that 
Spinomed significantly decreased back pain (P = 0.001) 
(evaluation was performed using visual analog scale at the 
beginning and 6 months follow-up of the examination) and 
increased personal isometric trunk muscle strength, (Table 1 
and Figure 1).34
Pfeifer et al also reported the effectiveness of Spinomed 
for stabilizing osteoporotic vertebral fractures. In their 
study the use of Spinomed was associated with a significant 
increase in trunk muscle strength, most likely because of 
increased muscular activity while wearing the orthosis.30
A program of physical therapy is necessary and helps 
prevent deformity by strengthening antigravity muscles and 
promoting postural retraining. Breathing exercises   promote 
thoracic expansion and improve the heavily degraded 
  pulmonary function found in patients with spinal   osteoporotic 
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Figure 1 Schematic presentation of values in personal isometric force in newton (n): 
Force (F)/weight (w) in abdominals and extensor muscles (F/w abdominals and 
F/w  ext,  respectively),  after  6  months  wearing  Spinomed  orthosis  (F:  force  in 
newton, w: weight in Kg).
Table 1 Differences in values of visual analog scale (vAS) and personal isometric force: force (F)/weight (w) in abdominals and 
extensors muscles (F/w abdominals and F/w extensors, respectively), after 6 months wearing Spinomed orthosis. (F: force in newton, 
w: weight in Kg) measured with ISO-rACK device (Digimax, ΜechaTronic, Germany)
Patients in the beginning of the study (1) vs patients wearing Spinomed for 6 months (2)
Variables Patients starting wearing Spinomed  
n = 10  
mean ± sd
Patients wearing Spinomed for 6 months  
n = 10  
mean ± sd
P-value
VAS (difference 
vAS 1 – vAS 2)
65 ± 16.5 41 ± 17 0.001
F/W abdominals 
(difference  
F/wabd 1 – F/wabd 2) (n)
131.1 ± 53.7 197.8 ± 82.7 0.005
F/W extensors  
(difference 
F/w ext 1 – F/w ext 2) (n)
197.6 ± 48 246.3 ± 59.5 0.003 International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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fractures.35 Instruction on the proper method of lifting things, 
as well as how to use a walker or a cane properly, could be 
beneficial and thus is strongly recommended.24,35 Patients 
with fractures could subject themselves to low-intensity 
exercise and gentle strengthening programs (eg, Tai Chi and 
hydrotherapy) and are strongly recommended to avoid high 
impact exercise or movements, so that they avoid suffering 
new vertebral fractures.29 Forward bending of the spine or 
flexion exercises, especially in combination with twisting, 
should be avoided.24,29 According to Bassey, this includes 
several old favorite exercises which are now considered 
outdated, namely straight-leg toe touches and sit ups (or 
crunches) for strengthening the abdominal muscles.36 Sinaki 
and Mikkelsen reported that the latter are associated with a 
dramatically increased rate of vertebral fracture in osteo-
porotic women (89% compared to 16% of those who did 
extension exercises).37 As the acute fracture pain subsides, 
a walking program can begin with gentle strengthening 
exercises focusing on spinal extensor muscles.38 A carefully 
supervised rehabilitation program should be started after 3 to 
4 months, to strengthen the spinal extensor and abdominal 
muscles more aggressively.24,39
Vertebroplasty and kyphoplasty
These procedures are different in several aspects. Vertebroplasty 
mainly involves the application of   polymethylmethacrylate 
(PMMA) to the fracture. This procedure is considered to be 
very successful in the stabilization of fractured osteoporotic 
vertebral body and in pain relief.40 A possible alternative is 
to inject calcium phosphate cement into a vertebral fracture, 
while in kyphoplasty a balloon is inserted to create space in 
the fractured vertebra, to restore its height and shape, before 
the balloch it is removed and the cement is delivered to the 
resulting space. Percutaneous vertebroplasty obtains early 
pain relief and improves the integrity of the osteoporotic 
vertebral body.41 On the other hand the mini-surgical inter-
vention may cause serious complications to patients with 
recent fractures, such as paraplegia,42 and the occurrence of 
a new vertebral body fracture, and possible cardiopulmo-
nary events.43 Two studies in 2009 concerning the efficacy 
of vertebroplasty may signal a different approach for this 
procedure.44,45 In the first study44 78 patients with one or 
two painful osteoporotic vertebral fractures were random-
ized in a multicenter, double-blind, placebo-controlled trial 
(vertebroplasty vs a sham procedure). The authors found no 
significant advantage for vertebroplasty at any time point 
during follow-up between groups with respect to pain at night 
and at rest, physical functioning, quality of life, and perceived 
improvement. Another study in 131 patients, with one to three 
painful osteoporotic vertebral fractures, randomized either in 
vertebroplasty or a sham procedure found similar results.45 
The authors noted a trend toward a higher rate of clinically 
meaningful improvement in pain in the vertebroplasty group 
but improved disability and pain scores were noted immedi-
ately following both procedures.
On the other hand a randomized controlled trial (Fracture 
Reduction Evaluation [FREE] trial) which took place at 
21 sites in eight countries and included 149 patients assigned 
to balloon kyphoplasty showed that in patients with acute, 
painful, vertebral fractures, balloon kyphoplasty improved 
quality of life, function, mobility, and pain more rapidly than 
did nonsurgical management, with significant differences in 
improvement between the groups at 1 month.46
Disclosure
No benefits in any form have been received or will be received 
from a commercial party related directly or   indirectly to the 
subject of this article.
References
  1.  Papaioannou A, Watts NB, Kendler DL, Yuen CK, Adachi JD, Ferko N. 
Diagnosis and management of vertebral fractures in elderly adults. Am 
J Med. 2002;113:220–228.
  2.  Yamaguchi T, Sugimoto T, Yamauchi M, Matsumori Y, Tsutsumi M, 
Chihara K. Multiple vertebral fractures are associated with refractory 
reflux esophagitis in postmenopausal women. J Bone Miner Metab. 
2005;23:36–40.
  3.  Tosi LL, Bouxsein ML, Johnell O. Commentary on the AAOS position 
statement: recommendations for enhancing the care for patients with 
fragility fractures. Tech Orthop. 2004;19:121–125.
  4.  Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ III. 
Population based study of survival after osteoporotic fractures. Am J 
Epidemiol. 1993;137:1001–1005.
  5.  Ismail AA, Cockerill W, Cooper C, et al. Prevalent vertebral deformity 
predicts incident hip though not distal forearm fracture: results from 
the European Prospective Osteoporosis Study. Osteoporos Int. 2001; 
12:85–90.
  6.  Gold DT. Osteoporosis and quality of life: psychosocial outcomes 
and interventions for individual patients. Clin Geriatr Med. 2003;19: 
271–280.
  7.  Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture 
in the year following a fracture. JAMA. 2001;285:320–323.
  8.  Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M, Kirkwood 
JR. Recognition of vertebral fracture in a clinical setting. Osteoporos 
Int. 2000;11:577–582.
  9.  Molsberger A, Jensen KU, Muller U, Winkelmann W, Wehling P. 
Chronic pain syndromes in orthopedics. Typical types, follow-up and 
patient characteristics. Z Orthop Ihre Grenzgeb. 1989;127:695–700.
  10.  Francis RM, Aspray TJ, Hide G, Sutcliffe AM, Wilkinson P. Back pain 
in osteoporotic vertebral fractures. Osteoporos Int. 2008;19:895–903.
  11.  Bouxsein ML, Kaufman J, Tosi L, Cummings S, Lane J, Johnell O. Rec-
ommendations for optimal care of the fragility fracture patient to reduce 
the risk of future fracture. J Am Acad Orthop Surg. 2004;12: 385–395.
  12.  Panneman MJ, Lips P, Sen SS, Herings RM. Undertreatment with anti-
osteoporotic drugs after hospitalization for fracture. Osteoporos Int. 
2004;15:120–124.International Journal of General Medicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-general-medicine-journal
The International Journal of General Medicine is an international, 
peer-reviewed open-access journal that focuses on general and internal 
medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-
ment protocols. The journal is characterized by the rapid reporting of 
reviews, original research and clinical studies across all disease areas. 
A key focus is the elucidation of disease processes and management 
protocols resulting in improved outcomes for the patient.The manu-
script management system is completely online and includes a very 
quick and fair peer-review system. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
171
 Management of osteoporotic vertebral fractures
  13.  Lyritis GP, Trovas G. Analgesic effects of calcitonin. Bone. 2002; 
30 Suppl 5:71S–74S.
  14.  Iwamoto J, Takeda T, Ichimura S, Uzawa M. Comparative effects of 
treatment with etidronate and alendronate on bone resorption, back pain, 
and activities of daily living in elderly women with vertebral fractures. 
Keio J Med. 2003;52:230–235.
  15.  Nevitt MC, Thompson DE, Black DM, et al. Effect of alendronate on 
limited activity days and bed-disability days caused by back pain in 
postmenopausal women with existing vertebral fractures. Fracture Inter-
vention Trial Research Group. Arch Intern Med. 2000;160:77–85.
  16.  Gangji V , Appelboom T. Analgesic effect of intravenous pamidronate 
on chronic back pain due to osteoporotic vertebral fractures. Clin 
Rheumatol. 1999;18:266–267.
  17.  Armingeat T, Brondino R, Pham T, Legré V , Lafforgue P. Intravenous 
pamidronate for pain relief in recent osteoporotic vertebral compression 
fracture: a randomized double-blind controlled study. Osteoporos Int. 
2006;17:1659–1665.
  18.  Ulivieri FM. Back pain treatment in post-menopausal osteoporosis with 
vertebral fractures. Aging Clin Exp Res. 2007;19 Suppl 3:21–23.
  19.  Nevitt MC, Chen P, Dore RK, et al. Reduced risk of back pain following 
teriparatide treatment: a meta-analysis. Osteoporos Int. 2006;17: 
273–280.
  20.  Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture 
in the year following a fracture. JAMA. 2001;285:320–323.
  21.  Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, Yiatzides A, 
Tsekoura M. Analgesic effect of salmon calcitonin in osteoporotic 
vertebral fractures: a double-blind placebo-controlled clinical study. 
Calcif Tissue Int. 1991;49:369–372.
  22.  Avenell A, Gillespie WJ, Gillespie LD, O’Connell D. Vitamin D and vita-
min D analogues for preventing fractures associated with involutional 
and post-menopausal osteoporosis. Cochrane Database of Syst Rev. 
2009;CD000227.
  23.  Lukert BP. Vertebral compression fractures: how to manage pain, 
avoiding disability. Geriatrics. 1994;49:22–26.
  24.  Dionyssiotis Y, Dontas IA, Economopoulos D, Lyritis GP. Rehabilitation 
after falls and fractures. J Musculoskelet Neuronal Interact. 2008; 
8:244–250.
  25.  Mazanec DJ, Podichetty VK, Mompoint A, Potnis A. Vertebral 
compression fractures: manage aggressively to prevent sequelae. Cleve 
Clin J Med. 2003;70:147–156.
  26.  Lyritis GP, Mayasis B, Tsakalakos N, et al. The natural history of 
the osteoporotic vertebral fracture. Clin Rheumatol. 1989;8 Suppl 2: 
66–69.
  27.  Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, 
Lyritis PG. Pain relief from nasal salmon calcitonin in osteoporotic 
vertebral fractures. A double blind, placebo controlled clinical study. 
Acta Orthop Scand. 1997;275(Suppl):112–114.
  28.  Lyritis GP, Ioannidis GV, Karachalios T, et al. Analgesic effect of 
salmon calcitonin suppositories in patients with acute pain due to recent 
osteoporotic vertebral crush fractures: a prospective double-blind, 
randomised, placebo-controlled clinical study. Clin J Pain. 1999;15: 
284–289.
  29.  Sinaki M, Lynn SG. Reducing the risk of falls through proprioceptive 
dynamic posture training in osteoporotic women with kyphotic 
posturing: a randomized pilot study. Am J Phys Med Rehabil. 2002; 
81:241–246.
  30.  Pfeifer M, Begerow B, Minne HW. Effects of a new spinal orthosis on 
posture, trunk strength, and quality of life in women with postmeno-
pausal osteoporosis: a randomized trial. Am J Phys Med Rehabil. 2004; 
83:177–186.
  31.  Hildebrandt HD, Vogt L. Der “Osteoporosebody” – eine multifunk-
tionale Orthese. Orthopädie-Technik. 2002;53:90–96.
  32.  Vogt L, Hübscher M, Brettmann K, Banzer W, Fink M. Postural 
correction by osteoporosis orthosis (Osteo-med): a randomized, 
placebo-controlled trial. Prosthet Orthot Int. 2008;32:103–110.
  33.  Kaplan RS, Sinaki M, Hameister MD. Effect of back supports on back 
strength in patients with osteoporosis: a pilot study. Mayo Clin Proc. 
1996;71:235–241.
  34.  Dionyssiotis Y, Michas G, Galanos A, Thoma S, Lyritis GP. A perspec-
tive study of spinal orthosis in postmenopausal women. Osteoporos Int. 
2009;20 Suppl 1:S23–S176.
  35.  Bonner FJ Jr, Sinaki M, Grabois M, et al. Health professional‘s guide to 
rehabilitation of the patient with osteoporosis. Osteoporos Int. 2003;14 
Suppl 2:S1–S22.
  36.  Bassey EJ. Exercise for prevention of osteoporotic fracture. Age Ageing. 
2001;30 Suppl 4:29–31.
  37.  Sinaki M, Mikkelsen BA. Postmenopausal spinal osteoporosis: 
flexion versus extension exercises. Arch Phys Med Rehabil. 1984;65: 
593–596.
  38.  Rapado A. General management of vertebral fractures. Bone. 1996; 
18:S191–S196.
  39.  Sinaki M. Musculoskeletal rehabilitation. In: Riggs BL, Melton LJ, 
editors. Osteoporosis: Etiology, Diagnosis, and Management. 2nd ed. 
Philadelphia: Lippincott-Raven; 1995:435–473.
  40.  Ahn DK, Lee S, Choi DJ, et al. Mechanical properties of blood-mixed 
polymethylmetacrylate in percutaneous vertebroplasty. Asian Spine J. 
2009;3:45–52.
  41.  Nakamo M, Hirano N, Matsuura K, et al. Percutaneous transpedicular 
vertebroplasty with calcium phosphate cement in the treatment of 
osteoporotic vertebral compression and burst fractures. J Neurosurg. 
2003;97 Suppl 3:287–293.
  42.  Lee BJ, Lee SR, Yoo TY. Paraplegia as a complication of percutaneous 
vertebroplasty with polymethylmethacrylate: a case report. Spine. 2002; 
27:E419–E422.
  43.  Uppin AA, Hirsch JA, Centenera LV, Pfiefer BA, Pazianos AG,   
Choi IS. Occurrence of new vertebral body fracture after perculaneous 
vertebroplasty in patients with osteoporosis. J Radiology. 2003;226: 
119–124.
  44.  Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of 
vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009; 
361:569–579.
  45.  Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of 
vertebroplasty for painful osteoporotic vertebral fractures. N Engl J 
Med. 2009;361:557–568.
  46.  Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety 
of balloon kyphoplasty compared with non-surgical care for vertebral 
compression fracture (FREE): a randomised controlled trial. Lancet. 
2009;373:1016–1024.